chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had them twice but I got the shot/suspected vaccination failure; had them twice; had them twice; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and shingles. On an unknown date, the outcome of the vaccination failure, shingles and shingles were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient. The age at vaccination was not reported. The patient had shingles twice, but he/she got the Shingles shot. The follow up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Headache,chills,fever,pain at injection site, Muscle pain joint pain,  tiredness  Started approx. 1 hr. after injection and lasted about18 hrs.  took Tylenol and  drank a lot of water.
72 hours after nausea and vomiting. Tinnitus on and off for two days.
Information has been received from a consumer concerning an 11 year old male who on 02/17/2003 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot # not reported). Subsequently the pt experienced pain and swelling in the injected arm. The school nurse examined the boy and saw no signs of swelling, however the pt was complaining of pain. Unspecified medical attention was sought. Additional info has been requested.
Bells  Palsy Signs and Symptoms  Right Side for the last 72 hours with ear pain and eye twitches.  noticeable onset this morning  1/30 with right eye right  and upper lip involvement.
Sustained a small granuloma at site of injection. This granuloma with surrounding bruising has persisted and not decreased in size despite warm soaks and compresses. There are not significant motor sequelae other than subcutaneous granuloma.
Distal parasthesias and numbness - worse in lower extremities occuring 3 days after immunization of Menactra.  On the 4th day patient went to the emergency room and had lab work and a CT scan to rule out Guillain-Barre Syndrome.  On the fifth day patient presented to Internal Medicine specialist who in turn consulted Neurology.  It was determined not to be Guillain-Barre syndrome because the patient still had all reflexes present.  The symptoms have slowly gone away.
Lip/tongue/facial numbness, headache, throat tightness, shortness of breath. I started taking prednisone, claritan and benadryl 1 hour after injection. The symptoms kept getting worse so I went to urgent care and received an inhaler. I'm one week out and all but the SOB have resoled. The SOB seems to be improving but I feel like I'm still somewhat in a fog. I had lesions in my mouth for 5 days.  I developed left sided enlarged lymph nodes, TMJ and ear pain for 2 days with discomfort in the left breast and axillary. This has resolved.  I had a follow up appt today (3/3/21) and was prescribed an Epi-Pen.
Mother misrepresented child's date of birth as 2016 and confirmed the child was 5 years old in order to gain vaccine Pediatrician's office notified pharmacy when report was sent to them Mother refuses to return call
Accute Endocarditis, 39 days hospitalized, second open heart surgery, 33 days ceftriaxzone  infusion, penicillin for life
Patient presented to Hospital ED on 7/6/2022 with shortness of breath, which had been present but worsened over past several days. Patient was chronically on 4 L of oxygen but for EMS on 4 L he was 85%. He did receive breathing treatments in the ambulance prior to arrival. Patient had been coughing up yellow phlegm, No fever. no chest pains. Patient appeared chronically ill. Heart rate was regular and tachycardic. Lung sounds were fairly clear anteriorly.  Patient had been recently admitted to the hospital on June 15, 2022 and discharged on the 30th. The patient was hospitalized for shortness of breath, persistent right lower lobe infiltrate, suspected relapsed stage IV right lung cancer. He had been on chronic Augmentin therapy since September 2021. His sputum culture on May 9, 2022 grew sensitive Pseudomonas. He was initially treated with Zosyn. Patient was not a candidate for lobectomy according to CT surgery. Patient did have IR drainage of abscess/mass on June 21, the culture was negative and the pathology showed necroinflammatory debris. The chart indicated admitting differential diagnoses included but not limited to pneumonia, COPD, other viral URI and positive for COVID-19 per PCR.  Public Health Department has no further information on this client. Please contact provider for any additional information.
Painful node in left armpit; Enlarged node in left armpit; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0178) via an unspecified route of administration in the left arm on 19May2021 at 15:30 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history included depression, GERD (gastroesophageal reflux disease), hypothyroidism and obstructive sleep apnea. Patient has allergy to penicillin. Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN) and pantoprazole sodium sesquihydrate (PROTONIX) all for unknown indications from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 28Apr2021 at 15:00 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 20May2021 at 03:00, the patient experienced enlarged and painful node in left armpit. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the adverse events. The clinical outcome of enlarged and painful node in left armpit was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
multiple sclerosis flare up; chills; fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MULTIPLE SCLEROSIS RELAPSE (multiple sclerosis flare up) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Multiple sclerosis.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced MULTIPLE SCLEROSIS RELAPSE (multiple sclerosis flare up) (seriousness criterion medically significant), CHILLS (chills) and FATIGUE (fatigue). At the time of the report, MULTIPLE SCLEROSIS RELAPSE (multiple sclerosis flare up), CHILLS (chills) and FATIGUE (fatigue) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment medication included prednisone which patient was taking until 29-Apr-2021.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This case was reported by a nurse via sales rep and described the occurrence of induration in a 16-year-old patient who received BEXSERO. On an unknown date, the patient received BEXSERO (intramuscular) .5 ml. On an unknown date, an unknown time after receiving BEXSERO, the patient experienced induration. On an unknown date, the outcome of the induration was unknown. The reporter considered the induration to be probably related to BEXSERO. Additional details were provided as follows: The age at vaccination was not reported.
Within 10 hours of the vaccine, that night, the next day, I was experiencing severe body aches, fever, extreme chills, headache, sweating, and almost passing out when I tried to walk from one room of house to another.
Started feeling very tired, and arm became extremely sore, 3 hours after my vaccination. Took Tylenol around 3pm, found I had a 100.1° fever that night (approx 8-9pm). Fever went up to 102.3° at 3am (next day).  Fever stayed around 99° the rest of the day, finally broke by 9pm when I was able to check because Tylenol was out of my system. Both days felt extreme fatigue. Day of vaccination was only able to do tasks for about 10 mins before needing to sit down.
Eryth papvesic rash- base of scalp, arms, trunk, legs, scantly scattered.
Fever of 101.7 with severe body aches, headache, chills, nausea
Been 72 days since he received the first dose but not the second dose; Got diagnosed with Corona disease; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Been 72 days since he received the first dose but not the second dose) and COVID-19 (Got diagnosed with Corona disease) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced COVID-19 (Got diagnosed with Corona disease). On 14-Jun-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Been 72 days since he received the first dose but not the second dose). On 14-Jun-2021, PRODUCT DOSE OMISSION ISSUE (Been 72 days since he received the first dose but not the second dose) had resolved. At the time of the report, COVID-19 (Got diagnosed with Corona disease) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided.  Treatment information was not provided.
Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported. No adverse reactions were reported by patient.  It was reported that there had been no power outages that would have impacted the Moderna vaccine. However, the Healthcare professional reiterated that because the facility was unable to download the digital data logger, they would need to treat the issue as a temperature excursion. The data logger was unable to download for the months of Dec 2021, Jan 2022, and Feb 2022. They were filling out a temperature excursion assessment at that time. It was reported that no adverse reactions were reported by any patient. Reporter confirmed that patients had administered doses while the temperature excursion assessment was ongoing.
Information has been received from an allergist physician who reported that he was asked to see a female patient who recently received her first dose of varicella virus vaccine live (Oka/Merck) and developed an injection site reaction. There was no rash. the patient sought unspecified medical attention. The physician did not see the patient as of this report and did not know anything else at this time. The patient's family physician administered the vaccine. No further information is available.
angioedema in her lips and up her face; pain; fevery feel; hives/ urticaria; nose became extremely stuffy; bruise on left arm and just now turning yellowish; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "allergy" (unspecified if ongoing); "hives" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Prednisone, notes: She just was off of Prednisone on the past week. The following information was reported: ANGIOEDEMA (medically significant), outcome "unknown", described as "angioedema in her lips and up her face"; PAIN (non-serious), outcome "unknown"; PYREXIA (non-serious), outcome "unknown", described as "fevery feel"; URTICARIA (non-serious), outcome "recovered", described as "hives/ urticaria"; NASAL CONGESTION (non-serious), outcome "recovered", described as "nose became extremely stuffy"; CONTUSION (non-serious), outcome "unknown", described as "bruise on left arm and just now turning yellowish". Therapeutic measures were taken as a result of pyrexia, urticaria, nasal congestion. Clinical course: Patient was actually afraid of taking the Pfizer Covid vaccine 2023-2024 formula as she had a history of allergy and hives. She just was off of prednisone on the past week. She had the previous Pfizer Covid vaccines, had all the dose and had no reactions on that. She's afraid because recently she had hives and wanted to know if she would go for the shot or not. Patient had urticaria recently. She was eating ice cream at (withheld), then her nose became extremely stuffy. She took antihistamine and it was cleared up instantly. She's due for her flu and COVID vaccines. Her doctor told her she needed to get the epi pen. She's concerned on how long does she have to wait before taking Comirnaty. She was told that chocolates and dairy products are a no-no. She's been trying to google and found out every person different reactions. She was told keep wearing mask until she get the allergy test on December. She's asking if Comirnaty had IgE (Immunoglobulin E). She's eating tomatoes and it has the same kind of proteins. She was told by her doctor to cover up her arms and legs. She's basically just been taking water and bread. She said she had a bad case in Sep (unspecified year), thought it was mosquito bites, had bruise on left arm and just now turning yellowish. She also had angioedema in her lips and up her face which she have never seen before. She said she didn't have any reactions to the previous Pfizer Covid vaccines except pain and fevery feel in which she took paracetamol (TYLENOL).   The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
my doctor told me to go ahead and take the third booster shot at month 6. I inadvertently took it a month early.; fever of 101.2/ fever of 101.2 wiped me out; Extreme Soreness at the inection site; All over Joint pain; I feel pretty bad; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (I feel pretty bad), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (my doctor told me to go ahead and take the third booster shot at month 6. I inadvertently took it a month early.), PYREXIA (fever of 101.2/ fever of 101.2 wiped me out), VACCINATION SITE PAIN (Extreme Soreness at the inection site) and ARTHRALGIA (All over Joint pain) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 055E21A, 020B71A and 025AZ1A) for COVID-19 vaccination.     Concurrent medical conditions included HIV disease since September 2010 and Penicillin allergy. Concomitant products included DOLUTEGRAVIR SODIUM, LAMIVUDINE (DOVATO) from October 2020 to an unknown date for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Sep-2021, the patient experienced FEELING ABNORMAL (I feel pretty bad) and PYREXIA (fever of 101.2/ fever of 101.2 wiped me out). 01-Sep-2021, the patient experienced VACCINATION SITE PAIN (Extreme Soreness at the inection site) and ARTHRALGIA (All over Joint pain). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (my doctor told me to go ahead and take the third booster shot at month 6. I inadvertently took it a month early.). On 04-Sep-2021, VACCINATION SITE PAIN (Extreme Soreness at the inection site) and ARTHRALGIA (All over Joint pain) had resolved. At the time of the report, FEELING ABNORMAL (I feel pretty bad), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (my doctor told me to go ahead and take the third booster shot at month 6. I inadvertently took it a month early.) and PYREXIA (fever of 101.2/ fever of 101.2 wiped me out) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high (High) fever of 101.2.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.   No treatment medication was reported.    Only on the 3rd day same symptoms experienced only at night. Resolved completely by the 4th day.   Most recent FOLLOW-UP information incorporated above includes: On 07-Sep-2021: Significant follow up. Patient details added. Concomitant medication updated. New AE like Extreme Soreness at Injection site and All over Joint Pain added.
This spontaneous report as received from a Licensed Practical Nurse via company representative, refers to a 16 year old female patient. On an unknown date the patient was vaccinated with the first dose of GARDASIL (lot number reported as K006447) (1 single shot, unspecified route and dose), intramuscular. Concomitant medications were not reported. The nurse reported that on an unspecified date after receiving the first dose of GARDASIL the patient (demographics unknown) fainted and was taken to the hospital (duration and demographics unknown) for a possible concussion. The outcome of patient fainted and possible concussion was not reported. The relationship between GARDASIL and the events was not reported. Additional information has been requested.
was feeling as though as she was going to faint; Her heart was beating fast soon; She also developed a rash to her arm and elbow.; was normally on time with cycle, and it had been off; This is a spontaneous report from a contactable consumer (patient's mother). A 26-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) at the age of 26 years old, dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1st dose, single, dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 2nd dose, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Mother was calling on behalf of her 26 years old daughter who had received both doses of the Pfizer Covid vaccine. A couple of weeks after the vaccine her daughter while in the shower, was feeling as though as she was going to faint, she was normally on time with cycle, and it had been off, her heart was beating fast soon after she got the vaccine, but it went away. she also developed a rash to her arm and elbow. The reporter asked if an abnormal cycle which has never had was part of the Pfizer Covid vaccine and what about infertility if there were any reports on whether the vaccine would cause infertility. The outcome of the event "Her heart was beating fast soon" was recovered on an unspecified date, of the other events was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
I have had a DAILY dull headache at the top of my head plus an ache at my lower neck since receiving my second vaccine shot.  On April 29, I had a nightmare during which I screamed in my sleep--I woke up with an aggravating headache.  It seems as though my stress hormones are triggered with the least bit of stress--even in a sleep state.  I'm wondering whether the ingredients in the pfizer vaccine are similar structure as the hormone cortisol.
father states pt devel fever approx 5 days p/immun; unsure what temp was; states had some sz, body jerking all over, face jerking lasted 10-15 seconds; mom of pt has hx of sz; pt given APAP on day of shots & day afterwards;
7/19/21: patient presents to ED with complaints of shortness of breath x 8 days, generalized body aches x3 days. tested positive for COVID-19 7 days prior. Reports having previously received the J&J COVID-19 vaccine in March (3/5/2021).  Diagnosed with COVID-19 pneumonia and hypoxia. received remdesivir. 7/23/21: discharged
Fever started within a couple hours after she received immunizations in our office. She also visited family the weekend of 1/15/11 and a few cousins also had fevers.